Clinical trials: Panic Attacks
Panic Disorder, Panic Disorder (With or Without Agoraphobia)
Qigong and Multicomponent Exercise in Panic Disorder
Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort.
- Conditions
- Panic Disorder, Panic Disorder (With or Without Agoraphobia), Panic Attacks and Disorders, Qigong
- Trial name
- NCT07439224
- Testing
- Exercise Training
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people
- Sponsor
- Dokuz Eylul University
Panic Attacks and Disorders
A Multi-Site RCT of a Stepped-Care Intervention for Emergency Department Patients With Panic Attacks and Panic Disorder
Using a randomized controlled trial (RCT) design, the main objective of this study is to evaluate the clinical, patient-centered, and economic effectiveness of a stepped-care intervention for patients with panic attacks and panic…
- Trial name
- NCT03632356
- Testing
- Stepped Care Intervention (STEP), Screening only
- Where
- Singapore
- Volunteers
- 79 people
- Sponsor
- Singapore General Hospital
PTSD, Panic Attacks
Exposure Therapy For Veterans With PTSD And Panic Attacks
To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid PTSD and panic disorder (PD).
- Trial name
- NCT01033136
- Testing
- Multiple Channel Exposure Therapy - Veterans, Cognitive Processing Therapy
- Where
- United States
- Volunteers
- 93 people
- Sponsor
- VA Office of Research and Development
Anxiety, Panic Attacks
Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department
Currently, there are limited options in the management of anxiety and panic attack symptoms in the Emergency Department (ED). The most common treatment method is the use of anti-anxiety and anti-depressant medications; however…
- Trial name
- NCT03884712
- Testing
- CalmiGo
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- Yves Duroseau
Panic Attacks, Chest Pain
The Effects of Treatment With Sertraline for Noncardiac Chest Pain
The purpose of this study is to determine whether care as usual or intervention (consisting of sertraline versus placebo), are effective in the treatment of panic disorder and/or depression driven noncardiac chest pain.
- Conditions
- Panic Attacks, Chest Pain, Depression
- Trial name
- NCT01114100
- Testing
- sertraline
- Where
- Netherlands
- Volunteers
- 210 people
- Sponsor
- Maastricht University Medical Center
Panic Disorder
Using the Canary Breathing System for Panic Disorder Patients
The purpose of this study is to test the effectiveness of the Canary Breathing System (CBS) in treating the symptoms of panic disorder.
- Trial name
- NCT01955954
- Testing
- Canary Breathing System
- Where
- 4 sites in United States
- Volunteers
- 69 people
- Sponsor
- Palo Alto Health Sciences, Inc.
Major Depression Moderate, Major Depression Severe
EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT
This study aims to investigate the neurophysiological and inflammatory changes associated with electroconvulsive therapy (ECT) in older age patients diagnosed with Major Depressive Episode, Major Depression, and Bipolar Disorder…
- Conditions
- Major Depression Moderate, Major Depression Severe, Major Depression With Comorbid Anxiety Symptoms, Major Depression With Panic Attacks
- Trial name
- NCT07740694
- Testing
- Electroconvulsive Therapy
- Where
- Turkey (Türkiye)
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- Istanbul University - Cerrahpasa
Dexmedetomidine, Panic Attacks
Dexmedetomidine Nasal Spray for the Treatment of Panic Attacks in Adults
Panic attacks affect 13.2% of adults globally, with acute treatments (e.g., benzodiazepines) carrying dependency risks. Dexmedetomidine, an α₂-adrenergic agonist, achieves peak plasma levels in 5-15 min via nasal delivery and may…
- Trial name
- NCT07162649
- Testing
- Dexmedetomidine
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Tongji University
Treatment of Induced Panic Attack
Staccato Alprazolam in Panic Attack
We are developing Staccato™ Alprazolam for the treatment of Panic attacks associated with panic disorder. This study will provide an initial assessment of efficacy, and to continue to describe the tolerability and…
- Trial name
- NCT00477451
- Testing
- Inhaled alprazolam 1 mg, Inhaled alprazolam 2 mg, IV doxapram
- Where
- 3 sites in United States
- Volunteers
- 49 people
- Sponsor
- Alexza Pharmaceuticals, Inc.
Panic Disorder
Imagery Rescripting for Traumatic Panic Attack Memories
The current project consists of two studies investigating the phenomenological characteristics, centrality levels, and traumatic symptoms of panic attack memories, while testing the effectiveness of the Imagery Rescripting (ImRs)…
- Trial name
- NCT07769996
- Testing
- Imagery Rescripting
- Where
- Turkey (Türkiye)
- Volunteers
- 32 people
- Sponsor
- İmge eylem yılmaz namlı
Panic Disorder
Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks.
- Trial name
- NCT00279617
- Testing
- levetiracetam
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Lindner Center of HOPE
Major Depressive Episode (MDE), Major Depressive Disorder (MDD)
LHC-CIDI-5 in Hong Kong
The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12…
- Conditions
- Major Depressive Episode (MDE), Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD), Suicidal Ideation
- Trial name
- NCT06804525
- Testing
- CIDI-5, LHC-CIDI-5
- Where
- Hong Kong
- Volunteers
- 2,500 people
- Sponsor
- The University of Hong Kong
Healthy
Staccato Alprazolam Single Dose PK
We are developing Staccato Alprazolam for the acute treatment of panic attacks associated with panic disorder.
- Trial name
- NCT00444522
- Testing
- Alprazolam thermal aerosol
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Alexza Pharmaceuticals, Inc.
Panic Disorder
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
The purpose of this study is to assess the long-term safety and tolerability of alprazolam extended release (XR) in adolescents with panic disorder, with or without agoraphobia, or in anxiety disorder with panic attacks.
- Trial name
- NCT00634790
- Testing
- alprazolam XR
- Where
- 47 sites in United States
- Volunteers
- 49 people
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Panic Disorder, Agoraphobia
Mechanisms of Panic Disorders Treatment
Investigation of mechanisms of exposure based learning by 1. Investigating the effects of fear augmentation by interoceptive exposure during in vivo exposure 2.
- Conditions
- Panic Disorder, Agoraphobia, Panic Attacks
- Trial name
- NCT01323556
- Testing
- Cognitive Behavioural Therapy (CBT)
- Where
- Germany
- Volunteers
- 180 people
- Sponsor
- University Medicine Greifswald
Obsessive Compulsive Disorder (OCD), Anxiety Disorder of Childhood or Adolescence
Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD
Anxiety disorders in children and adolescents are common and confer significant disability. Cognitive behavioral therapy (CBT) is the recommended treatment for youth with anxiety, yet many families cannot access CBT due to cost…
- Conditions
- Obsessive Compulsive Disorder (OCD), Anxiety Disorder of Childhood or Adolescence, Social Anxiety Disorder of Childhood, Generalized Anxiety Disorder (GAD)
- Trial name
- ASTRO (NCT07024758)
- Testing
- Parent Coached Exposure Therapy, Family Based, Internet-Based Cognitive Behavioral Therapy
- Where
- United States
- Volunteers
- 174 people
- Sponsor
- Baylor College of Medicine